These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severe asthma in childhood: diagnostic and management challenges. Bozzetto S; Carraro S; Zanconato S; Baraldi E Curr Opin Pulm Med; 2015 Jan; 21(1):16-21. PubMed ID: 25415405 [TBL] [Abstract][Full Text] [Related]
4. Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment? Fitzpatrick AM; Moore WC J Allergy Clin Immunol Pract; 2017; 5(4):901-908. PubMed ID: 28689840 [TBL] [Abstract][Full Text] [Related]
5. Managing severe asthma in adults: lessons from the ERS/ATS guidelines. Chung KF Curr Opin Pulm Med; 2015 Jan; 21(1):8-15. PubMed ID: 25405672 [TBL] [Abstract][Full Text] [Related]
6. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies. Chung KF J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339 [TBL] [Abstract][Full Text] [Related]
7. Workup of Severe Asthma. Couillard S; Jackson DJ; Wechsler ME; Pavord ID Chest; 2021 Dec; 160(6):2019-2029. PubMed ID: 34265308 [TBL] [Abstract][Full Text] [Related]
8. Phenotype-Driven Therapeutics in Severe Asthma. Opina MT; Moore WC Curr Allergy Asthma Rep; 2017 Feb; 17(2):10. PubMed ID: 28233153 [TBL] [Abstract][Full Text] [Related]
9. Airway Inflammatory Biomarker: Could It Tailor the Right Medications for the Right Asthmatic Patient? Zedan MM; Osman AM; Laimon WN; Zedan MM; Abo-Elkheir NY; Zaki A Iran J Immunol; 2016 Jun; 13(2):70-88. PubMed ID: 27350629 [TBL] [Abstract][Full Text] [Related]
10. The dark side of the moon: severe therapy-resistant asthma in children. de Benedictis FM; Carloni I; Bush A Monaldi Arch Chest Dis; 2012 Jun; 77(2):83-93. PubMed ID: 23193845 [TBL] [Abstract][Full Text] [Related]
11. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Petsky HL; Li A; Chang AB Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221 [TBL] [Abstract][Full Text] [Related]
12. Applying personalized medicine to adult severe asthma. Tiotiu A Allergy Asthma Proc; 2021 Jan; 42(1):e8-e16. PubMed ID: 33404396 [No Abstract] [Full Text] [Related]
13. Severe Asthma in Childhood. Marko A; Ross KR Immunol Allergy Clin North Am; 2019 May; 39(2):243-257. PubMed ID: 30954174 [TBL] [Abstract][Full Text] [Related]
14. [Asthma in clinical practice: from inflammatory phenotypes to personalized treatment]. Schleich F; Graff S; Bougard N; Frix AN; Peerboom S; Demarche S; Guissard F; Paulus V; Henket M; Calmès D; Moermans C; Louis R Rev Med Liege; 2022 May; 77(5-6):289-294. PubMed ID: 35657185 [TBL] [Abstract][Full Text] [Related]
15. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385 [TBL] [Abstract][Full Text] [Related]
16. Precision medicine in asthma: linking phenotypes to targeted treatments. Chung KF Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and Management of Severe Asthma. Chung KF Semin Respir Crit Care Med; 2018 Feb; 39(1):91-99. PubMed ID: 29427989 [TBL] [Abstract][Full Text] [Related]
18. Steroid response in refractory asthmatics. Jang AS Korean J Intern Med; 2012 Jun; 27(2):143-8. PubMed ID: 22707883 [TBL] [Abstract][Full Text] [Related]
19. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils. Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328 [TBL] [Abstract][Full Text] [Related]